News Agency
Men's Weekly

Alebund's Innovative Investigational Drug AP303 Receives FDA Orphan Drug Designation (ODD) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  • Written by PR Newswire

SHANGHAI, March 29, 2024 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic conditions, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation...

Read more: Alebund's Innovative Investigational Drug AP303 Receives FDA Orphan Drug Designation (ODD) for the...

Furniture Movers Sydney: Complete Guide to Safe and Efficient Moving

Moving furniture in a busy city like Sydney can be a complex task. High rise apartments, narrow streets, traffic congestion, and strict building regulations all add extra challenges to the moving process. Whether you are relocating your home or office... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion